| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.088 | 0.005 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.006 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.12 | 0.007 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.007 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.089 | 0.008 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |